APO Research
Talk to an analyst

APO RESEARCH · REPORT

Women's Health Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Women's Health Drugs Industry Growth and Trends Forecast to 2032

23 December 202597 pages

Choose your research edition.

Industry ResearchWomen's Health Drugs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Women's Health Drugs Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Women's Health Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Women's Health Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Women's Health Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Women's Health Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Women's Health Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Women's Health Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Women's Health Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Women's Health Drugs include Merck & Co., Pfizer, GlaxoSmithKline, Bayer AG, AbbVie Inc, Therapeutics MD and Allergan Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Women's Health Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Women's Health Drugs market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Women's Health Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Women's Health Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Women's Health Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Women's Health Drugs Market by Company

Merck & Co.

Pfizer

GlaxoSmithKline

Bayer AG

AbbVie Inc

Therapeutics MD

Allergan Plc

Women's Health Drugs Segment by Type

Contraceptives Drug

Infertility Drug

Polycystic Ovary Syndrome Drug

Menopause Drug

Postmenopausal Osteoporosis Drug

Endometriosis Drug

Others

Women's Health Drugs Segment by Application

Elderly Women

Young Women

Little Girls

Women's Health Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Women's Health Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Women's Health Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Women's Health Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Women's Health Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Women's Health Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Contraceptives Drug Table 2. Major Company of Infertility Drug Table 3. Major Company of Polycystic Ovary Syndrome Drug Table 4. Major Company of Menopause Drug Table 5. Major Company of Postmenopausal Osteoporosis Drug Table 6. Major Company of Endometriosis Drug Table 7. Major Company of Others Table 8. Global Women's Health Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Women's Health Drugs Sales by Type (2021-2026) & (k tons) Table 10. Global Women's Health Drugs Sales Market Share in Volume by Type (2021-2026) Table 11. Global Women's Health Drugs Sales by Type (2021-2026) & (US$ Million) Table 12. Global Women's Health Drugs Sales Market Share in Value by Type (2021-2026) Table 13. Global Women's Health Drugs Price by Type (2021-2026) & (US$/kg) Table 14. Global Women's Health Drugs Sales by Type (2027-2032) & (k tons) Table 15. Global Women's Health Drugs Sales Market Share in Volume by Type (2027-2032) Table 16. Global Women's Health Drugs Sales by Type (2027-2032) & (US$ Million) Table 17. Global Women's Health Drugs Sales Market Share in Value by Type (2027-2032) Table 18. Global Women's Health Drugs Price by Type (2027-2032) & (US$/kg) Table 19. North America Women's Health Drugs Sales by Type (2021-2026) & (k tons) Table 20. North America Women's Health Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Women's Health Drugs Sales by Type (2021-2026) & (k tons) Table 22. Europe Women's Health Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Women's Health Drugs Sales by Type (2021-2026) & (k tons) Table 24. Asia-Pacific Women's Health Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Women's Health Drugs Sales by Type (2021-2026) & (k tons) Table 26. Latin America Women's Health Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Women's Health Drugs Sales by Type (2021-2026) & (k tons) Table 28. Middle East and Africa Women's Health Drugs Sales by Type (2021-2026) & (US$ Million) Table 29. Women's Health Drugs Industry Trends Table 30. Women's Health Drugs Industry Drivers Table 31. Women's Health Drugs Industry Opportunities and Challenges Table 32. Women's Health Drugs Industry Restraints Table 33. Global Women's Health Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Women's Health Drugs Revenue Market Share by Company (2021-2026) Table 35. Global Women's Health Drugs Sales by Company (2021-2026) & (k tons) Table 36. Global Women's Health Drugs Sales Share by Company (2021-2026) Table 37. Global Women's Health Drugs Market Price by Company (2021-2026) & (US$/kg) Table 38. Global Women's Health Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Women's Health Drugs Major Company Production Sites and Headquarters Table 40. Global Women's Health Drugs Company, Product Type & Application Table 41. Global Women's Health Drugs Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Women's Health Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Women's Health Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Women's Health Drugs Sales by Region (2021-2026) & (k tons) Table 46. Global Women's Health Drugs Sales Market Share in Volume by Region (2021-2026) Table 47. Global Women's Health Drugs Sales by Region (2021-2026) & (US$ Million) Table 48. Global Women's Health Drugs Sales Market Share in Value by Region (2021-2026) Table 49. Global Women's Health Drugs Sales (k tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 50. Global Women's Health Drugs Sales by Region (2027-2032) & (k tons) Table 51. Global Women's Health Drugs Sales Market Share in Volume by Region (2027-2032) Table 52. Global Women's Health Drugs Sales by Region (2027-2032) & (US$ Million) Table 53. Global Women's Health Drugs Sales Market Share in Value by Region (2027-2032) Table 54. Global Women's Health Drugs Sales (k tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 55. Global Women's Health Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Women's Health Drugs Sales by Application (2021-2026) & (k tons) Table 57. Global Women's Health Drugs Sales Market Share in Volume by Application (2021-2026) Table 58. Global Women's Health Drugs Sales by Application (2021-2026) & (US$ Million) Table 59. Global Women's Health Drugs Sales Market Share in Value by Application (2021-2026) Table 60. Global Women's Health Drugs Price by Application (2021-2026) & (US$/kg) Table 61. Global Women's Health Drugs Sales by Application (2027-2032) & (k tons) Table 62. Global Women's Health Drugs Sales Market Share in Volume by Application (2027-2032) Table 63. Global Women's Health Drugs Sales by Application (2027-2032) & (US$ Million) Table 64. Global Women's Health Drugs Sales Market Share in Value by Application (2027-2032) Table 65. Global Women's Health Drugs Price by Application (2027-2032) & (US$/kg) Table 66. North America Women's Health Drugs Sales by Application (2021-2026) & (k tons) Table 67. North America Women's Health Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Women's Health Drugs Sales by Application (2021-2026) & (k tons) Table 69. Europe Women's Health Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Women's Health Drugs Sales by Application (2021-2026) & (k tons) Table 71. Asia-Pacific Women's Health Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Women's Health Drugs Sales by Application (2021-2026) & (k tons) Table 73. Latin America Women's Health Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Women's Health Drugs Sales by Application (2021-2026) & (k tons) Table 75. Middle East and Africa Women's Health Drugs Sales by Application (2021-2026) & (US$ Million) Table 76. Merck & Co. Company Information Table 77. Merck & Co. Business Overview Table 78. Merck & Co. Women's Health Drugs Sales (k tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. Merck & Co. Women's Health Drugs Product Portfolio Table 80. Merck & Co. Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Women's Health Drugs Sales (k tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. Pfizer Women's Health Drugs Product Portfolio Table 85. Pfizer Recent Development Table 86. GlaxoSmithKline Company Information Table 87. GlaxoSmithKline Business Overview Table 88. GlaxoSmithKline Women's Health Drugs Sales (k tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 89. GlaxoSmithKline Women's Health Drugs Product Portfolio Table 90. GlaxoSmithKline Recent Development Table 91. Bayer AG Company Information Table 92. Bayer AG Business Overview Table 93. Bayer AG Women's Health Drugs Sales (k tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 94. Bayer AG Women's Health Drugs Product Portfolio Table 95. Bayer AG Recent Development Table 96. AbbVie Inc Company Information Table 97. AbbVie Inc Business Overview Table 98. AbbVie Inc Women's Health Drugs Sales (k tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 99. AbbVie Inc Women's Health Drugs Product Portfolio Table 100. AbbVie Inc Recent Development Table 101. Therapeutics MD Company Information Table 102. Therapeutics MD Business Overview Table 103. Therapeutics MD Women's Health Drugs Sales (k tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 104. Therapeutics MD Women's Health Drugs Product Portfolio Table 105. Therapeutics MD Recent Development Table 106. Allergan Plc Company Information Table 107. Allergan Plc Business Overview Table 108. Allergan Plc Women's Health Drugs Sales (k tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 109. Allergan Plc Women's Health Drugs Product Portfolio Table 110. Allergan Plc Recent Development Table 111. North America Women's Health Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 112. North America Women's Health Drugs Sales by Country (2021-2026) & (k tons) Table 113. North America Women's Health Drugs Sales Market Share by Country (2021-2026) Table 114. North America Women's Health Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 115. North America Women's Health Drugs Sales Market Share Forecast by Country (2027-2032) Table 116. North America Women's Health Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Women's Health Drugs Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Women's Health Drugs Market Share by Country (2021-2026) Table 119. North America Women's Health Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Women's Health Drugs Market Share Forecast by Country (2027-2032) Table 121. Europe Women's Health Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 122. Europe Women's Health Drugs Sales by Country (2021-2026) & (k tons) Table 123. Europe Women's Health Drugs Sales Market Share by Country (2021-2026) Table 124. Europe Women's Health Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 125. Europe Women's Health Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Women's Health Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Women's Health Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Women's Health Drugs Market Share by Country (2021-2026) Table 129. Europe Women's Health Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Women's Health Drugs Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Women's Health Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Women's Health Drugs Sales by Country (2021-2026) & (k tons) Table 133. Asia-Pacific Women's Health Drugs Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Women's Health Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 135. Asia-Pacific Women's Health Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Women's Health Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Women's Health Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Women's Health Drugs Market Share by Country (2021-2026) Table 139. Asia-Pacific Women's Health Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Women's Health Drugs Market Share Forecast by Country (2027-2032) Table 141. Latin America Women's Health Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 142. Latin America Women's Health Drugs Sales by Country (2021-2026) & (k tons) Table 143. Latin America Women's Health Drugs Sales Market Share by Country (2021-2026) Table 144. Latin America Women's Health Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 145. Latin America Women's Health Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Women's Health Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Women's Health Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Women's Health Drugs Market Share by Country (2021-2026) Table 149. Latin America Women's Health Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Women's Health Drugs Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Women's Health Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Women's Health Drugs Sales by Country (2021-2026) & (k tons) Table 153. Middle East and Africa Women's Health Drugs Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Women's Health Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 155. Middle East and Africa Women's Health Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Women's Health Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Women's Health Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Women's Health Drugs Market Share by Country (2021-2026) Table 159. Middle East and Africa Women's Health Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Women's Health Drugs Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Women's Health Drugs Distributors List Table 164. Women's Health Drugs Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Women's Health Drugs Image Figure 2. Global Women's Health Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Women's Health Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Women's Health Drugs Sales (2021-2032) & (k tons) Figure 5. Contraceptives Drug Image Figure 6. Global Contraceptives Drug Sales YoY Growth (2021-2032) & (k tons) Figure 7. Infertility Drug Image Figure 8. Global Infertility Drug Sales YoY Growth (2021-2032) & (k tons) Figure 9. Polycystic Ovary Syndrome Drug Image Figure 10. Global Polycystic Ovary Syndrome Drug Sales YoY Growth (2021-2032) & (k tons) Figure 11. Menopause Drug Image Figure 12. Global Menopause Drug Sales YoY Growth (2021-2032) & (k tons) Figure 13. Postmenopausal Osteoporosis Drug Image Figure 14. Global Postmenopausal Osteoporosis Drug Sales YoY Growth (2021-2032) & (k tons) Figure 15. Endometriosis Drug Image Figure 16. Global Endometriosis Drug Sales YoY Growth (2021-2032) & (k tons) Figure 17. Others Image Figure 18. Global Others Sales YoY Growth (2021-2032) & (k tons) Figure 19. Global Women's Health Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Women's Health Drugs Market Share by Type 2025 VS 2032 Figure 21. North America Women's Health Drugs Sales Market Share in Volume by Type in 2025 Figure 22. North America Women's Health Drugs Sales Market Share in Value by Type in 2025 Figure 23. Europe Women's Health Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Europe Women's Health Drugs Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Women's Health Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Women's Health Drugs Sales Market Share in Value by Type in 2025 Figure 27. Latin America Women's Health Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Women's Health Drugs Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Women's Health Drugs Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Women's Health Drugs Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Women's Health Drugs Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Elderly Women Image Figure 34. Global Elderly Women Sales YoY Growth (2021-2032) & (k tons) Figure 35. Young Women Image Figure 36. Global Young Women Sales YoY Growth (2021-2032) & (k tons) Figure 37. Little Girls Image Figure 38. Global Little Girls Sales YoY Growth (2021-2032) & (k tons) Figure 39. Global Women's Health Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Women's Health Drugs Market Share by Application 2025 VS 2032 Figure 41. North America Women's Health Drugs Sales Market Share in Volume by Application in 2025 Figure 42. North America Women's Health Drugs Sales Market Share in Value by Application in 2025 Figure 43. Europe Women's Health Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Europe Women's Health Drugs Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Women's Health Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Women's Health Drugs Sales Market Share in Value by Application in 2025 Figure 47. Latin America Women's Health Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Women's Health Drugs Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Women's Health Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Women's Health Drugs Sales Market Share in Value by Application in 2025 Figure 51. North America Women's Health Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 52. North America Women's Health Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Women's Health Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Women's Health Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Women's Health Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 56. Europe Women's Health Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Women's Health Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Women's Health Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Women's Health Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 60. Asia-Pacific Women's Health Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Women's Health Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Women's Health Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Women's Health Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 64. Latin America Women's Health Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Women's Health Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Women's Health Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Women's Health Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 68. Middle East and Africa Women's Health Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Women's Health Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Women's Health Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Women's Health Drugs Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Women's Health Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Contraceptives Drug
  • Infertility Drug
  • Polycystic Ovary Syndrome Drug
  • Menopause Drug
  • Postmenopausal Osteoporosis Drug
  • Endometriosis Drug
  • Others
Applications
  • Elderly Women
  • Young Women
  • Little Girls
Companies covered
  • Merck & Co.
  • Pfizer
  • GlaxoSmithKline
  • Bayer AG
  • AbbVie Inc
  • Therapeutics MD
  • Allergan Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Women's Health Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Women's Health Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Women's Health Drugs Market by Type
  6. 1.3.1 Contraceptives Drug
  7. 1.3.2 Infertility Drug
  8. 1.3.3 Polycystic Ovary Syndrome Drug
  9. 1.3.4 Menopause Drug
  10. 1.3.5 Postmenopausal Osteoporosis Drug
  11. 1.3.6 Endometriosis Drug
  12. 1.3.7 Others
  13. 1.4 Global Women's Health Drugs Market Size by Type
  14. 1.4.1 Global Women's Health Drugs Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Women's Health Drugs Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Women's Health Drugs Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Women's Health Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Women's Health Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Women's Health Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Women's Health Drugs Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Women's Health Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Women's Health Drugs Industry Trends
  2. 2.2 Women's Health Drugs Industry Drivers
  3. 2.3 Women's Health Drugs Industry Opportunities and Challenges
  4. 2.4 Women's Health Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Women's Health Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Women's Health Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Women's Health Drugs Price (2021-2026)
  4. 3.4 Global Women's Health Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Women's Health Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Women's Health Drugs Company, Product Type & Application
  7. 3.7 Global Women's Health Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Women's Health Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Women's Health Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Women's Health Drugs Tier 1, Tier 2, and Tier 3
4 Women's Health Drugs Regional Status and Outlook
  1. 4.1 Global Women's Health Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Women's Health Drugs Historic Market Size by Region
  3. 4.2.1 Global Women's Health Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Women's Health Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Women's Health Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Women's Health Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Women's Health Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Women's Health Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Women's Health Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Women's Health Drugs by Application
  1. 5.1 Women's Health Drugs Market by Application
  2. 5.1.1 Elderly Women
  3. 5.1.2 Young Women
  4. 5.1.3 Little Girls
  5. 5.2 Global Women's Health Drugs Market Size by Application
  6. 5.2.1 Global Women's Health Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Women's Health Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Women's Health Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Women's Health Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Women's Health Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Women's Health Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Women's Health Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Women's Health Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck & Co.
  2. 6.1.1 Merck & Co. Company Information
  3. 6.1.2 Merck & Co. Business Overview
  4. 6.1.3 Merck & Co. Women's Health Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck & Co. Women's Health Drugs Product Portfolio
  6. 6.1.5 Merck & Co. Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Women's Health Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Women's Health Drugs Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline Women's Health Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline Women's Health Drugs Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 Bayer AG
  20. 6.4.1 Bayer AG Company Information
  21. 6.4.2 Bayer AG Business Overview
  22. 6.4.3 Bayer AG Women's Health Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer AG Women's Health Drugs Product Portfolio
  24. 6.4.5 Bayer AG Recent Developments
  25. 6.5 AbbVie Inc
  26. 6.5.1 AbbVie Inc Company Information
  27. 6.5.2 AbbVie Inc Business Overview
  28. 6.5.3 AbbVie Inc Women's Health Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AbbVie Inc Women's Health Drugs Product Portfolio
  30. 6.5.5 AbbVie Inc Recent Developments
  31. 6.6 Therapeutics MD
  32. 6.6.1 Therapeutics MD Company Information
  33. 6.6.2 Therapeutics MD Business Overview
  34. 6.6.3 Therapeutics MD Women's Health Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Therapeutics MD Women's Health Drugs Product Portfolio
  36. 6.6.5 Therapeutics MD Recent Developments
  37. 6.7 Allergan Plc
  38. 6.7.1 Allergan Plc Company Information
  39. 6.7.2 Allergan Plc Business Overview
  40. 6.7.3 Allergan Plc Women's Health Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Allergan Plc Women's Health Drugs Product Portfolio
  42. 6.7.5 Allergan Plc Recent Developments
7 North America by Country
  1. 7.1 North America Women's Health Drugs Sales by Country
  2. 7.1.1 North America Women's Health Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Women's Health Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Women's Health Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Women's Health Drugs Market Size by Country
  6. 7.2.1 North America Women's Health Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Women's Health Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Women's Health Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Women's Health Drugs Sales by Country
  2. 8.1.1 Europe Women's Health Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Women's Health Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Women's Health Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Women's Health Drugs Market Size by Country
  6. 8.2.1 Europe Women's Health Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Women's Health Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Women's Health Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Women's Health Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Women's Health Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Women's Health Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Women's Health Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Women's Health Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Women's Health Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Women's Health Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Women's Health Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Women's Health Drugs Sales by Country
  2. 10.1.1 South America Women's Health Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Women's Health Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Women's Health Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Women's Health Drugs Market Size by Country
  6. 10.2.1 South America Women's Health Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Women's Health Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Women's Health Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Women's Health Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Women's Health Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Women's Health Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Women's Health Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Women's Health Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Women's Health Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Women's Health Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Women's Health Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Women's Health Drugs Value Chain Analysis
  2. 12.1.1 Women's Health Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Women's Health Drugs Production Mode & Process
  7. 12.2 Women's Health Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Women's Health Drugs Distributors
  10. 12.2.3 Women's Health Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst